1.?Dai, M., et al. (2015). 'Curing mice with large tumors by locally? delivering combinations of immunomodulatory antibodies'? Clin Cancer Res 21(5): 1127-1138.
2.?Zippelius, A., et al. (2015). 'Induced PD-L1 expression mediates? acquired resistance to agonistic anti-CD40 treatment' Cancer Immunol? Res 3(3): 236-244. 3.?Redmond, W. L., et al. (2014). 'Combined targeting of costimulatory? (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T? cells capable of driving robust antitumor immunity' Cancer Immunol? Res 2(2): 142-153. 4.?Condamine, T., et al. (2014). 'ER stress regulates myeloid-derived? suppressor cell fate through TRAIL-R-mediated apoptosis' J Clin Invest? 124(6): 2626-2639. 5.?Muller, P., et al. (2014). 'Microtubule-depolymerizing agents used in? antibody-drug conjugates induce antitumor immunity by stimulation of? dendritic cells' Cancer Immunol Res 2(8): 741-755. 6.?Bulliard, Y., et al. (2013). 'Activating Fc gamma receptors contribute? to the antitumor activities of immunoregulatory receptor-targeting? antibodies' J Exp Med 210(9): 1685-1693. |